Importance The recent proliferation of phosphorylated tau (p-tau) biomarkers has raised
questions about their preferential association with the hallmark pathologies of Alzheimer …

Animal studies suggest that the apolipoprotein E ε4 (APOEε4) allele is a culprit of early
microglial activation in Alzheimer’s disease (AD). Here, we tested the association between …

An unresolved question for the understanding of Alzheimer’s disease (AD) pathophysiology
is why a significant percentage of amyloid-β (Aβ)-positive cognitively unimpaired (CU) …

Astrocytes can adopt multiple molecular phenotypes in the brain of Alzheimer’s disease (AD)
patients. Here, we studied the associations of cerebrospinal fluid (CSF) glial fibrillary acidic …

Importance Neuropsychiatric symptoms are commonly encountered and are highly debilitating
in patients with Alzheimer disease. Understanding their underpinnings has implications …

The mechanisms by which the apolipoprotein E ε4 (APOEε4) allele influences the
pathophysiological progression of Alzheimer’s disease (AD) are poorly understood. Here we tested …

The γ-aminobutyric acid (GABA)ergic system is the primary inhibitory neurotransmission
system in the mammalian brain. Its dysregulation has been shown in multiple brain conditions, …

Introduction Plasma biomarkers—cost effective, non‐invasive indicators of Alzheimer's
disease (AD) and related disorders (ADRD)—have largely been studied in clinical research …

Introduction In Alzheimer’s disease clinical research, glial fibrillary acidic protein (GFAP)
released/leaked into the cerebrospinal fluid and blood is widely measured and perceived as a …

Attention-deficit/hyperactivity disorder (ADHD) persists in older age and is postulated as a
risk factor for cognitive impairment and Alzheimer’s Disease (AD). However, these findings …